Forge Biologics, part of Ajinomoto Bio-Pharma Services, is partnering with Restore Vision on a gene therapy for retinitis ...

New research suggests a path forward that could change the lives of millions around the world. It may lead to a breakthrough for people who are losing vision due to retinal damage and conditions like ...

A tiny wireless chip placed at the back of the eye is giving people with severe vision loss something they had been told they would never regain: the ability to see letters, shapes and even words ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Electronic retinal implants like the PRIMA system can partially restore central vision in ...

Patients with untreatable conditions such as sight loss or loss of motor function could be closer to a viable technology for restoring their lost sense within a faster time frame. This is due to the ...

Age-related macular degeneration (AMD) is an untreatable vision loss problem impacting those over 50. The disease starts as a thinning of the macula (the part of the retina responsible for detailed ...

Researchers have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons. Researchers at the ...

Restore Vision, Inc. ("Restore Vision"), a clinical-stage biotechnology company advancing gene therapies for retinal disorders, and Forge Biologics ("Forge"), a leading manufacturer of gene therapies ...